Meloxicam and Atomoxetine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Meloxicam (meloxicam) and Atomoxetine (atomoxetine). Common drug interactions include fall among females and confusional state among males.

The phase IV clinical study analyzes what interactions people have when they take Meloxicam and Atomoxetine. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,016 Meloxicam users. Check the latest studies of Meloxicam.

What is Atomoxetine?

Atomoxetine has active ingredients of atomoxetine. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 1,363 Atomoxetine users. Check the latest studies of Atomoxetine.

On Jul, 14, 2026

13 people who take Meloxicam and Atomoxetine together, and have interactions are studied.

Meloxicam and Atomoxetine drug interactions.

What are the common drug interactions of Meloxicam and Atomoxetine, by gender? *:

female:

Fall
Limb discomfort (discomfort in leg)
Fatigue (feeling of tiredness)
Dyspnoea (difficult or laboured respiration)
Pruritus (severe itching of the skin)
Adverse drug reaction
Alopecia (absence of hair from areas of the body)
Anaphylactic reaction (serious allergic reaction)
Anxiety
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)

male:

Confusional state
Delirium (wild excitement)
Hypersensitivity
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Dizziness
Fatigue (feeling of tiredness)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Chronic kidney disease

What are the common drug interactions of Meloxicam and Atomoxetine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Erythema (redness of the skin)
Facial pain
Photosensitivity reaction
Pruritus (severe itching of the skin)

20-29:

n/a

30-39:

n/a

40-49:

Alopecia (absence of hair from areas of the body)
Anaphylactic reaction (serious allergic reaction)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Chills (felling of cold)
Chronic kidney disease
Dry throat
Dyspnoea (difficult or laboured respiration)
Emotional distress
Heart rate increased

50-59:

Confusional state
Delirium (wild excitement)
Pneumonia
Pruritus (severe itching of the skin)
Swollen tongue (swelling of tongue)
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Dizziness
Fatigue (feeling of tiredness)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Anxiety

60+:

n/a

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 23.08%
Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 15.38%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 15.38%
Hypersensitivity: 2 people, 15.38%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 15.38%
Thyroid Diseases: 1 person, 7.69%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 1 person, 7.69%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 7.69%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 7.69%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Meloxicam and Atomoxetine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously